BE894228A - Composition pharmaceutique pour le traitement de l'atherosclerose - Google Patents

Composition pharmaceutique pour le traitement de l'atherosclerose

Info

Publication number
BE894228A
BE894228A BE0/208897A BE208897A BE894228A BE 894228 A BE894228 A BE 894228A BE 0/208897 A BE0/208897 A BE 0/208897A BE 208897 A BE208897 A BE 208897A BE 894228 A BE894228 A BE 894228A
Authority
BE
Belgium
Prior art keywords
atherosclerosis
treatment
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
BE0/208897A
Other languages
English (en)
Original Assignee
Coughlin Shaun R
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Coughlin Shaun R filed Critical Coughlin Shaun R
Publication of BE894228A publication Critical patent/BE894228A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BE0/208897A 1981-08-27 1982-08-27 Composition pharmaceutique pour le traitement de l'atherosclerose BE894228A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29707681A 1981-08-27 1981-08-27

Publications (1)

Publication Number Publication Date
BE894228A true BE894228A (fr) 1982-12-16

Family

ID=23144754

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/208897A BE894228A (fr) 1981-08-27 1982-08-27 Composition pharmaceutique pour le traitement de l'atherosclerose

Country Status (7)

Country Link
JP (1) JPS5865224A (fr)
AU (1) AU8770282A (fr)
BE (1) BE894228A (fr)
DE (1) DE3232031A1 (fr)
FR (1) FR2511869A1 (fr)
GB (1) GB2105192A (fr)
IT (1) IT1153185B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1233412B (it) * 1987-12-02 1992-03-30 Acraf Uso del trazodone
US5006526A (en) * 1988-10-17 1991-04-09 Louisiana State University Method of treating a vertebrate animal to reduce plasma triglycerides and cholesterol levels and to alleviate and prevent atherosclerosis
EP0813873B1 (fr) * 1996-06-19 2002-02-13 Akzo Nobel N.V. Compositions pharmaceutiques comprenants de la mirtazapine et un ou plusieurs inhibiteurs sélectifs d'assimilation de sérotonine
IL121076A (en) * 1996-06-19 2000-10-31 Akzo Nobel Nv Pharmaceutical combinations comprising mirtazapine and one or more selective serotonin reuptake inhibitors
DE19900674A1 (de) * 1999-01-11 2000-07-13 Basf Ag Bindungspartner für 5-HT5-Rezeptoren zur Migränebehandlung
DE10043124A1 (de) 2000-08-31 2002-03-14 Max Delbrueck Centrum Verfahren zur Diagnostik von neuronalen Erkrankungen sowie zur Behandlung der defizienten primären Hämostase

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH553161A (de) * 1970-10-30 1974-08-30 Hoffmann La Roche Verfahren zur herstellung von phenylalaninderivaten.
DE2930369A1 (de) * 1979-07-26 1981-02-05 Rentschler Arzneimittel Arzneimittelloesungen

Also Published As

Publication number Publication date
AU8770282A (en) 1983-03-03
FR2511869A1 (fr) 1983-03-04
GB2105192A (en) 1983-03-23
JPS5865224A (ja) 1983-04-18
IT1153185B (it) 1987-01-14
DE3232031A1 (de) 1983-05-05
IT8223020A0 (it) 1982-08-27

Similar Documents

Publication Publication Date Title
BE890648A (fr) Compositions pour le traitement de l'acne
BE851328A (fr) Composition pour le traitement de l'hypercholesterolemie
FR2508318B1 (fr) Bandage pour l'administration d'une substance pharmaceutique
FR2503562B1 (fr) Conditionnement pharmaceutique pour le traitement des symptomes de menopause
MA18939A1 (fr) Procede de preparation d'un agent pour le traitement de theilerioses
PT75499A (fr) Procede pour la preparation de l'alkanoilanilides
FR2499408B1 (fr) Composition pharmaceutique pour le traitement de l'osteopathie, a base d'acide 6-amino-1-hydroxyhexane-1,1-diphosphonique
MC1525A1 (fr) Preparation d'une composition pour le traitement de la seborrhee
FR2558372B1 (fr) Composition medicamenteuse pour le traitement de l'acne
BE894228A (fr) Composition pharmaceutique pour le traitement de l'atherosclerose
FR2277591A1 (fr) Composition pharmaceutique pour la prevention et le traitement de l'alcoolisme
MA20655A1 (fr) Compositions pour le traitement de textiles
FR2536995B1 (fr) Composition pour le traitement de l'arthrite
BE872908A (fr) Compositions pharmaceutiques pour le traitement de l'hypertension
FR2340737A1 (fr) Composition pour le traitement de l'hypercholesterolemie
BE894172A (fr) Compositions pour le traitement des coccidioses a base d'amidino-urees
FR2526792B1 (fr) Derives d'aletheine utiles pour le traitement des lesions hepatiques
FR2544614B1 (fr) Nouvelle association medicamenteuse pour le traitement de l'hypertension
FR2517203B1 (fr) Composition pour le traitement de l'acne
RO87007A (fr) Procede et installation pour la preparation de l'isomerose
RO79428A2 (fr) Composition medicamenteuse pour le traitement des dermatoses
FR2334362A1 (fr) Composition pharmaceutique pour le traitement de l'hyperuricemie
FR2562798B1 (fr) Agent pharmaceutique pour le traitement du psoriasis
BE892339A (fr) Agents pour le traitement d'affections cardiaques coronariennes
BE892781A (fr) Nouvelles compositions pharmaceutiques pour le traitement du diabete

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: COUGHLIN SHAUN R.

Effective date: 19840827